Viewing Study NCT04544202


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:48 AM
Study NCT ID: NCT04544202
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-11-12
First Post: 2020-09-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module